Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma.

× No keyword cloud information.

6 in total

Review 1. Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy.

Authors: Ha Gyeong Shin; Ha Rim Yang; Aerin Yoon; Sukmook Lee
Journal: Int J Mol Sci Date: 2022-05-19 Impact factor: 6.208

Review 2. Advances in Immunotherapy for Diffuse Large B Cell Lymphoma.

Authors: Geoffrey Shouse; Alex F Herrera
Journal: BioDrugs Date: 2021-07-15 Impact factor: 5.807

Review 3. Immunotherapy of Acute Lymphoblastic Leukemia and Lymphoma With T Cell-Redirected Bispecific Antibodies.

Authors: Federico Lussana; Giuseppe Gritti; Alessandro Rambaldi
Journal: J Clin Oncol Date: 2021-01-12 Impact factor: 44.544

Review 4. Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma.

Authors: Pier Luigi Zinzani; Giorgio Minotti
Journal: J Cancer Res Clin Oncol Date: 2021-11-06 Impact factor: 4.553

Review 5. Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma.

Authors: Aleksandra Kusowska; Matylda Kubacz; Marta Krawczyk; Aleksander Slusarczyk; Magdalena Winiarska; Malgorzata Bobrowicz
Journal: Int J Mol Sci Date: 2022-01-28 Impact factor: 5.923

6. An autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodies.

Authors: Tobias Roider; Berit J Brinkmann; Vladislav Kim; Mareike Knoll; Carolin Kolb; Philipp M Roessner; Marie Bordas; Peter Dreger; Carsten Müller-Tidow; Wolfgang Huber; Martina Seiffert; Sascha Dietrich
Journal: Blood Adv Date: 2021-12-14

6 in total